APA

Pak E., MacKenzie E. L., Zhao X., Pazyra-Murphy M. F., Park P. M. C., Wu L., Shaw D. L., Addleson E. C., Cayer S. S., Lopez B. G., Agar N. Y. R., Rubin L. L., Qi J., Merk D. J. & Segal R. A. (20201110). A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. : Neuro-oncology.

Chicago

Pak Ekaterina, MacKenzie Ethan L, Zhao Xuesong, Pazyra-Murphy Maria F, Park Paul M C, Wu Lei, Shaw Daniel L, Addleson Emily C, Cayer Suzanne S, Lopez Begoña G-C, Agar Nathalie Y R, Rubin Lee L, Qi Jun, Merk Daniel J and Segal Rosalind A. 20201110. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. : Neuro-oncology.

Harvard

Pak E., MacKenzie E. L., Zhao X., Pazyra-Murphy M. F., Park P. M. C., Wu L., Shaw D. L., Addleson E. C., Cayer S. S., Lopez B. G., Agar N. Y. R., Rubin L. L., Qi J., Merk D. J. and Segal R. A. (20201110). A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. : Neuro-oncology.

MLA

Pak Ekaterina, MacKenzie Ethan L, Zhao Xuesong, Pazyra-Murphy Maria F, Park Paul M C, Wu Lei, Shaw Daniel L, Addleson Emily C, Cayer Suzanne S, Lopez Begoña G-C, Agar Nathalie Y R, Rubin Lee L, Qi Jun, Merk Daniel J and Segal Rosalind A. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. : Neuro-oncology. 20201110.